Sun Pharma, Cipla recall medicines in US over manufacturing issues

NationalIANS
Advertisement
New Delhi, Jan 26 : Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).

In its Enforcement Report, the US health regulator said the US-based arm of Mumbai-headquartered Sun Pharma is recalling more than 26,000 bottles of a generic medicine used to treat dandruff and skin conditions that cause inflammation and itching.

Sun Pharmaceutical Industries Inc, which is based in Princeton, New Jersey, is recalling 24,624 bottles of Fluocinolone Acetonide Topical Solution after the product failed to meet impurity and degradation standards.

The company initiated a nationwide Class III recall in the US on December 30, 2025. The USFDA said a Class III recall is issued in cases where the use of the product is not likely to cause any adverse health effects.

The regulator also said Sun Pharma is recalling certain batches of Clindamycin Phosphate USP, a medicine used to treat acne vulgaris.

This recall was initiated on November 26, 2025, after test results showed impurity levels and assay values were outside acceptable limits. This recall has also been classified as Class III.

Separately, the USFDA said a US-based arm of Cipla has recalled over 15,000 syringes from the American market.

Cipla USA Inc, which is headquartered in Warren, New Jersey, is recalling 15,221 pre-filled syringes of Lanreotide Injection due to the presence of particulate matter.

Cipla initiated a nationwide Class II recall on January 2 this year. According to the USFDA, a Class II recall is issued when the use of a product may cause temporary or medically reversible health effects, though the chances of serious harm are low.

The US remains the world’s largest pharmaceutical market, making regulatory compliance and product quality especially important for drugmakers operating in the country.

Advertisement

Note: The content of this article is sourced from a news agency and has not been edited by the ap7am team.

Sun PharmaCiplaUSFDAdrug recallpharmaceutical industrymanufacturing issuesFluocinolone AcetonideLanreotide InjectionClass II recallClass III recall

More News

Chinmoy Krishna Das transferred to Dhaka prison amid lack of transparency concerns surrounding his case

17 Nov, 13:16

Travis Head set to miss IPL 2027 due to workload management

17 Nov, 12:43

India's development and ASEAN's prosperity deeply interconnected: PM Modi

17 Nov, 12:30

BRS leader Harish Rao accuses Congress of 'unkept promises'

17 Nov, 11:57

‘Akvan’ set to intensify into severe cyclone by evening; Andhra CM takes stock of situation

17 Nov, 11:24

Six Pakistani soldiers killed in 4 drone Ops across Balochistan: BLA

17 Nov, 11:09

13 killed in three separate road accidents in Uttarakhand; CM Dhami expresses grief

17 Nov, 11:03

Rupee gains 31 paise against US dollar amid falling crude oil prices

17 Nov, 10:41

Gas leak from ONGC well in Andhra’s Konaseema district triggers panic

17 Nov, 10:39

'Seven batters, four pacers': Gill reveals India's combinations for Test series opener vs NZ

17 Nov, 10:35

Different religions don't have equal place in American identity: US preacher

17 Nov, 10:20

Two public safety officers shot in New York; gunman found dead

17 Nov, 10:11

Former India Caucus co-chair Jim McDermott dies at 89

17 Nov, 10:10

Third US aircraft carrier arrives in Middle East amid Iran tensions

17 Nov, 10:09

Vance says Trump will avoid ‘forever war’ in Iran

17 Nov, 10:08

US court strikes down fixed stay rule for international students, exchange visitors

17 Nov, 10:07

Iran says another 'violating' oiler caught fire in Hormuz, denies air defence activity in central province

17 Nov, 10:05

US touts truck-driver crackdown as safety gain

17 Nov, 09:50

2027 UP polls: SP, Cong to hold seat-sharing negotiations in Delhi today

17 Nov, 09:49

Indian American Congressman seeks $1,700 Iran war refund for families

17 Nov, 08:59
..More News